References

  1. Terézhalmy GT, Huber MA, Jones AC. Physical evaluation in dental practice, 1st ed. Ames, IA. Wiley-Blackwell. 2009.
  2. ClinCalc DrugStats. About the DrugStats Database. Drug Usage Statistics for the United States (2004 to 2014). Accesseed September 19, 2017.
  3. 3. U.S. National Library of Medicine. DailyMed. Advanced Search. Accesseed September 19, 2017.
  4. Sugar AM. Fungi - The Merck manual of diagnosis and therapy, 19th edition. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1319-1335.
  5. Ma C, Armstrong AW. Pharmacology of fungal infections. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4nd ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:661-673.
  6. Antifungal Drugs. Treat Guidel Med Lett. 2012 Aug;10(120):61-8.
  7. Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15; 62(4):e1–e50. doi: 10.1093/cid/civ933.
  8. Axéll T, Samaranayake LP, Reichart PA, et al. A proposal for reclassification of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Aug;84(2):111-2.
  9. Kaye KM. Viruses - The Merck manual of diagnosis and therapy, 19th edition. Robert S. Porter (Ed). Whitehouse station, NJ. Merck Sharp & Dohme Corp. 2011:1394-1401.
  10. Li JZ, Coen DM. Pharmacology of viral infections. Principles of Pharmacology: The pathophysiologic basis of drug therapy, 4nd ed. David E. Golan (Ed). Philadelphia, PA. Wolters Kluwer. 2017:694-722.
  11. Antiviral Drugs. Treat Guidel Med Lett. 2013 Mar;11(127):19-30.
  12. Usatine RP, Tinitigan R. Nongenital herpes simplex virus. Am Fam Physician. 2010 Nov 1;82(9):1075-82.
  13. Drugs for HIV Infection. Treat Guidel Med Lett. 2014 Feb;12(138):7-16.
  14. Arduino PG, Porter SR. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med. 2008 Feb;37(2):107-21. doi: 10.1111/j.1600-0714.2007.00586.x.
  15. Amir J, Harel L, Smetana Z, et al. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ. 1997 Jun 21;314(7097):1800-3.
  16. Glenny AM, Fernandez Mauleffinch LM, Pavitt S, et al. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006706. doi: 10.1002/14651858.CD006706.pub2.
  17. Spruance SL, Bodsworth N, Resnick H, et al. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol. 2006 Jul;55(1):47-53. doi: 10.1016/j.jaad.2006.02.031.
  18. Hull C, McKeough M, Sebastian K, et al. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. J Eur Acad Dermatol Venereol. 2009 Mar;23(3):263-7. doi: 10.1111/j.1468-3083.2008.03047.x. Epub 2009 Jan 8.
  19. Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med. 1993 Feb 15;118(4):268-72.
  20. Baker D, Eisen D. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Cutis. 2003 Mar;71(3):239-42.
  21. Miserocchi E, Modorati G, Galli L, et al. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol. 2007 Oct;144(4):547-51. Epub 2007 Aug 9.
  22. Miller CS, Cunningham LL, Lindroth JE, et al. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. J Am Dent Assoc. 2004 Sep;135(9):1311-8.
  23. Sacks SL, Thisted RA, Jones TM, et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol. 2001 Aug;45(2):222-30. doi: 10.1067/mjd.2001.116215.
  24. Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA. 1997 May 7;277(17):1374-9.
  25. Spruance SL, Nett R, Marbury T, et al. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother. 2002 Jul;46(7):2238-43.

Additional Resources

  • No Additional Resources Available